Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2316-2325

  Frasci, Giuseppe ^a   Panza, Nicola ^a   Comella, Pasquale ^a   Nicolella, Gianpaolo P ^a   Natale, Michele ^a   Manzione, Luigi ^a   Bilancia, Domenico ^a   Cioffi, Riccardo ^a   Maiorino, Luigi ^a   De Cataldis, Giuseppe ^a   Belli, Mario ^a   Micillo, Enrico ^a   Mascia, Vittorio ^a   Massidda, Bruno ^a   Lorusso, Vito ^a   De Lena, Mario ^a   Carpagnano, Francesco ^a   Contu, Antonio ^a   Pusceddu, Guido ^a   Comella, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; THROMBOCYTOPENIA;

EID: 0032766474     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2316     Document Type: Review

References (38)

1. Gralla R: New directions in non-small cell lung cancer. Semin Oncol 17:14-19, 1990(suppl 7)
2. Non-small Cell Lung Cancer Cooperative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
3. Lilenbaum RC, Green MR: Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 11:1391-1402, 1993
4. Comis RL, Friedland DM: New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the Seventh World Conference on Lung Cancer. Lung Cancer 12:S63-S69, 1995 (suppl 2)
5. Chang AY, Kim K, Click J, Anderson T, Karp D, Johnson D: Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst 85:388-394, 1993
6. Murphy WK, Fossella FV, Winn RJ, et al: Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 85:384-388, 1993
7. Klastersky J, Sculier JP: Dose-finding of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer: European Lung Cancer Working Party. Lung Cancer 12:S117-S125, 1995 (suppl 2)
8. Langer CJ, Leighton JC, Comis RL, et al: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
9. Greco FA, Hainsworth JD: Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: Results of a multicenter Phase II trial. Semin Oncol 24:5-12-14-8-12-17, 1997 (suppl 12)
10. Bonomi P, Kim K, Kluger J, Johnson D: Comparison of survival for stage IIIB versus IV non-small cell lung cancer patients treated with etoposide-cisplatin versus Taxol-cisplatin: An Eastern Cooperative Group trial. Proc Am Soc Clin Oncol 16:454a, 1997 (abstr 1631)
11. Giaccone G, Splinter TA, Debruyne C, et al: Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer: The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 16:2133-2141, 1998
12. Anderson H, Lund B, Bach F, Thacher N, Walling J, Hansen HH: Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: Aphase II study. J Clin Oncol 12:1821-1826, 1994
13. Gatzmeier U, Sheperd FA, Le Chevalier T, et al: Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre extended phase II study. Eur J Cancer 32A:243-248, 1996
14. Perng RP, Chen YM, Ming-Liu J, et al: Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. J Clin Oncol 15:2097-2102, 1997
15. Crinò L, Scagliotti G, Marangolo M, et al: Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase D study. J Clin Oncol 15:297-303, 1997
16. Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ: Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 15:744-750, 1997
17. Anton A, Artal A, Carrato A, et al: Gemcitabine plus cisplatin in advanced NSCLC: Final phase II results. Proc Am Soc Clin Oncol 16:461a, 1997 (abstr 1656)
18. Cardenal F, Rosell R, Anton A, et al: Gemcitabine + cisplatin vs. etoposide + cisplatin in advanced NSCLC patients: Preliminaryrandomized phase III results. Proc Am Soc Clin Oncol 16:458a, 1997 (abstr 1648)
19. Simon R, Wittes RE, Ellenberg SS: Randomized phase II clinical trials. Cancer Treat Rep 69:1375-1381, 1985
20. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47:207-214, 1981
21. Kaplan ES, Meier P: Non parametric estimation for incomplete observations. J Am Stat Assoc 53:557-580, 1958
22. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM: Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale. Eur J Cancer 29A:S51-S58, 1993 (suppl 1)
23. Frasci G, Comella P, Panza N, et al: Carboplatin-oral etoposide personalised dosing in elderly non-small cell lung cancer patients. Eur J Cancer 34:1710-1714, 1998
24. Comella P, Frasci G, Panza N, et al: Gemcitabine (GEM)-cisplatin (CDDP)-vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC): A Southern Italy Cooperative Oncology Group phase II randomized study. J Clin Oncol 17:1526-1534, 1999
25. Sorensen JB, Stenbyggard LE, Hansen HH, Dombernowsky P: Biweekly paclitaxel, gemcitabine, and cisplatin in non-resectable non-small cell lung cancer. Proc Am Soc Clin Oncol 17:501a, 1998 (abstr 1930)
26. Hainsworth JD, Erland JB, Kalman LA, et al: Phase I/II trial of paclitaxel (1-hour infusion) carboplatin, and gemcitabine in the treatment of advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 17:471a, 1998 (abstr 1811)
27. Kelly K, Prindville S, Bunn PA: A phase I trial of paclitaxel, carboplatin and gemcitabine in advanced non-small cell lung cancer: A University of Colorado Cancer Center study. Proc Am Soc Clin Oncol 17:490a, 1998 (abstr 1885)
28. Favaretto A, Paccagnella A, Tumolo S, et al: Paclitaxel and carboplatin in combination with gemcitabine (PCG): A phase I-II trial in non-small cell lung cancer. Ann Oncol 9:91, 1998 (suppl 4, abstr 438P)
29. Giaccone G, Smit E, Laan D, Splinter T, van Meerbeek J, Postmus P: Phase I/II study of paclitaxel and gemcitabine in advanced-non-small cell lung cancer. Proc Am Soc Clin Oncol 17:486a, 1998 (abstr 1869)
30. Rothenberg ML, Sharma A, Weiss GR, et al: Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. Ann Oncol 9:733-738, 1998
31. Androulakis N, Kourousis C, Kakolyris S, et al: Salvage treatment with paclitaxel and gemcitabine for patients with non-small cell lung cancer after cisplatin-or docetaxel-based chemotherapy: A multicenter phase II study. Ann Oncol 9:1127-1130, 1998
32. Einhorn LH, Raghavan D, Kindler H, Gordon M, Fox S, Meyers T: A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors. Proc Am Soc Clin Oncol 17:207a, 1998 (abstr 796)
33. Akerley W, Glantz M, Choy H, et al: Phase I trial of weekly paclitaxel in advanced lung cancer. J Clin Oncol 16:153-158, 1998
34. van der Burg MEL, de Wit R, Stoter G, Verweij J: Phase I study of weekly cisplatin and weekly or 4-weekly taxol: A highly active regimen in advanced epithelial ovarian cancer. Proc Am Soc Clin Oncol 17:355a, 1998 (abstr 1370)
35. Gianni L, Kearns C, Giani A, et al: Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol 13:180-190, 1995
36. Crinò L, Conte P, De Marinis F, et al: A randomized trial of gemcitabine, cisplatin versus mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer: A multicenter phase III study. Proc Am Soc Clin Oncol 17:455a, 1998 (abstr 1750)
37. Belani CP, Natale RB, Lee JS, et al: Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small cell lung cancer. Proc Am Soc Clin Oncol 17:455a, 1998 (abstr 1751)
38. Gatzemeier U, von Pawel J, Gottfried M, et al: Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 17:454a, 1998 (abstr 1748)